[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Biotekster Biotech-ster Biotech-ster posts on X about $mltx, dip, core scientific, $mltxs the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::976248243028869120/interactions)  - X Week XXXXX +38% - X Month XXXXX +650% - X Months XXXXXX -XX% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::976248243028869120/posts_active)  - X Week X no change - X Month XX +280% - X Months XX -XX% - X Year XXX -XX% ### Followers: XXX [#](/creator/twitter::976248243028869120/followers)  - X Week XXX +1.50% - X Month XXX +1.20% - X Months XXX +13% - X Year XXX +3.20% ### CreatorRank: undefined [#](/creator/twitter::976248243028869120/influencer_rank)  ### Social Influence [#](/creator/twitter::976248243028869120/influence) --- **Social category influence** [finance](/list/finance) XXXX% [stocks](/list/stocks) XXXX% **Social topic influence** [$mltx](/topic/$mltx) #5, [dip](/topic/dip) 3.33%, [core scientific](/topic/core-scientific) 3.33%, [$mltxs](/topic/$mltxs) 3.33%, [eli lilly](/topic/eli-lilly) 3.33%, [novartis](/topic/novartis) 3.33%, [$abbv](/topic/$abbv) XXXX% **Top accounts mentioned or mentioned by** [@alex68803248](/creator/undefined) [@mayemusk](/creator/undefined) [@xai](/creator/undefined) [@sonun629](/creator/undefined) [@ramabdu](/creator/undefined) [@kobeissiletter](/creator/undefined) [@khameneiir](/creator/undefined) [@jimmckay132](/creator/undefined) [@palestine001](/creator/undefined) [@jnetmargarita](/creator/undefined) [@abierkhatib](/creator/undefined) [@cherylwroteit](/creator/undefined) [@osint613](/creator/undefined) [@cdntradegrljenn](/creator/undefined) [@cyrilramaphosa](/creator/undefined) [@gregymarket](/creator/undefined) [@aprilspark1890](/creator/undefined) [@catturd2](/creator/undefined) [@sarah4trump](/creator/undefined) [@adamfeuerstein](/creator/undefined) **Top assets mentioned** [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Core Scientific, Inc. Common Stock (CORZ)](/topic/core-scientific) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Novartis AG (NVS)](/topic/novartis) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts [#](/creator/twitter::976248243028869120/posts) --- Top posts by engagements in the last XX hours "@jimmckay132 $mltx However implied volatility has decreased and the demand for puts has waned. Now it can freely move with the market. A Green Day for SPY and LABU will be a Green Day for MLTX" [X Link](https://x.com/Biotekster/status/1978777223550075362) [@Biotekster](/creator/x/Biotekster) 2025-10-16T10:57Z XXX followers, XXX engagements "$mltx the run up on Friday was sufficient for me to sell to lock in gain and re-enter on Monday. Past $XX the rest is unknown. A chance of it North of $XX is achievable" [X Link](https://x.com/Biotekster/status/1972164383607603382) [@Biotekster](/creator/x/Biotekster) 2025-09-28T05:00Z XXX followers, XXX engagements "$mltx with so many Institutional buyers coming out with filings buying this dip $12+ Could be spectacular day and week" [X Link](https://x.com/Biotekster/status/1977165252149363015) [@Biotekster](/creator/x/Biotekster) 2025-10-12T00:11Z XXX followers, XXX engagements "$mltx from Grok Feuerstein s misses tend to come on stock price predictions or M&A speculation (20-30% wrong) not core scientific critiques like $MLTXs VELA setup. For $MLTX specifically his bear case hinges on sonelokimab underperforming vs. Bimzelx due to trial design and benchmark issuesclassic Feuerstein territory where hes rarely off (10% miss rate). But if VELAs Phase X data exceeds expectations (e.g. HiSCR75 significantly above Bimzelxs 33-36%) he could be in that slim XX% wrong bucket. Keep an eye on his X posts (@adamfeuerstein) for real-time updates post-readout" [X Link](https://x.com/Biotekster/status/1972325464183328852) [@Biotekster](/creator/x/Biotekster) 2025-09-28T15:40Z XXX followers, XXX engagements "$mltx Companies that would benefit by a buyout of $mltx Merck & Co. UCB Pharma Eli Lilly Novartis AbbVie Johnson & Johnson Bristol Myers" [X Link](https://x.com/Biotekster/status/1972809363107799537) [@Biotekster](/creator/x/Biotekster) 2025-09-29T23:42Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Biotekster Biotech-ster
Biotech-ster posts on X about $mltx, dip, core scientific, $mltxs the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +38%
- X Month XXXXX +650%
- X Months XXXXXX -XX%
- X Year XXXXXX -XX%
Mentions: X #
- X Week X no change
- X Month XX +280%
- X Months XX -XX%
- X Year XXX -XX%
Followers: XXX #
- X Week XXX +1.50%
- X Month XXX +1.20%
- X Months XXX +13%
- X Year XXX +3.20%
CreatorRank: undefined #
Social Influence #
Social category influence finance XXXX% stocks XXXX%
Social topic influence $mltx #5, dip 3.33%, core scientific 3.33%, $mltxs 3.33%, eli lilly 3.33%, novartis 3.33%, $abbv XXXX%
Top accounts mentioned or mentioned by @alex68803248 @mayemusk @xai @sonun629 @ramabdu @kobeissiletter @khameneiir @jimmckay132 @palestine001 @jnetmargarita @abierkhatib @cherylwroteit @osint613 @cdntradegrljenn @cyrilramaphosa @gregymarket @aprilspark1890 @catturd2 @sarah4trump @adamfeuerstein
Top assets mentioned MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Core Scientific, Inc. Common Stock (CORZ) Eli Lilly and Company (LLY) Novartis AG (NVS) AbbVie Inc (ABBV)
Top Social Posts #
Top posts by engagements in the last XX hours
"@jimmckay132 $mltx However implied volatility has decreased and the demand for puts has waned. Now it can freely move with the market. A Green Day for SPY and LABU will be a Green Day for MLTX"
X Link @Biotekster 2025-10-16T10:57Z XXX followers, XXX engagements
"$mltx the run up on Friday was sufficient for me to sell to lock in gain and re-enter on Monday. Past $XX the rest is unknown. A chance of it North of $XX is achievable"
X Link @Biotekster 2025-09-28T05:00Z XXX followers, XXX engagements
"$mltx with so many Institutional buyers coming out with filings buying this dip $12+ Could be spectacular day and week"
X Link @Biotekster 2025-10-12T00:11Z XXX followers, XXX engagements
"$mltx from Grok Feuerstein s misses tend to come on stock price predictions or M&A speculation (20-30% wrong) not core scientific critiques like $MLTXs VELA setup. For $MLTX specifically his bear case hinges on sonelokimab underperforming vs. Bimzelx due to trial design and benchmark issuesclassic Feuerstein territory where hes rarely off (10% miss rate). But if VELAs Phase X data exceeds expectations (e.g. HiSCR75 significantly above Bimzelxs 33-36%) he could be in that slim XX% wrong bucket. Keep an eye on his X posts (@adamfeuerstein) for real-time updates post-readout"
X Link @Biotekster 2025-09-28T15:40Z XXX followers, XXX engagements
"$mltx Companies that would benefit by a buyout of $mltx Merck & Co. UCB Pharma Eli Lilly Novartis AbbVie Johnson & Johnson Bristol Myers"
X Link @Biotekster 2025-09-29T23:42Z XXX followers, XXX engagements